Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 9/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8874328 | 0.82 | ADORA2B (0.55) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL8872884 | 0.81 | ADORA2B (0.65) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL8879270 | 0.80 | ADORA2B (0.52) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL8872400 | 0.77 | ADORA2B (0.69) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL8975352 | 0.77 | ADORA2B (0.55) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL7276352 | 0.76 | ADORA2B (0.65) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL661108 | 0.75 | ADORA2B (1.00) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL14564546 | 0.74 | ADORA2B (0.79) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL10674822 | 0.74 | ADORA2B (0.70) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL1948455 | 0.73 | ADORA2B (1.00) | ADORA2BADORA2AKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5696124-A | Xanthine derivatives with adenosine-antagonistic activity | BOEHRINGER INGELHEIM KG (DE) | 1997-12-09 | — | — | US | disclosed |
| US-5532368-A | CHOLINOMIMETIC AGENTS; ALZHEIMER*S DISEASE; CENTRAL NERVOUS SYSTEM DISORDERS | BOEHRINGER INGELHEIM GMBH (DE) | 1996-07-02 | — | — | US | disclosed |
| EP-0374808-B1 | Xanthin derivatives having an adenosin-antagonist activity | BOEHRINGER INGELHEIM KG (DE) | 1996-04-17 | — | — | EP | disclosed |
| US-5175291-A | Reaction of 1,4-dioxaspiro 4,4!nonan-7-carboxylic acid with carbonyldiimidazole with 5,6-diamino-1,3-dipropyluracil in the presence of calcium hydroxide and hydroxylating | BOEHRINGER INGELHEIM KG (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0374808-A2 | Xanthin derivatives having an adenosin-antagonist activity | BOEHRINGER INGELHEIM KG (DE) | 1990-06-27 | — | — | EP | disclosed |